12925 studies found for:    Canada
Show Display Options
Rank Status Study
1 Completed Radiation Therapy and Chemotherapy in Treating Patients With Hodgkin's Disease
Condition: Hodgkin Lymphoma
Interventions: Biological: bleomycin sulfate;   Drug: dacarbazine;   Drug: doxorubicin hydrochloride;   Drug: vinblastine;   Radiation: radiation therapy
2 Terminated G-PLUS (GALLANT, GALLEX and ARMOR - Post Treatment Follow-up Study)
Condition: Type 2 Diabetes
Intervention:
3 Completed
Has Results
The Effect Of Dose Titration And Dose Tapering On The Tolerability Of DVS SR In Women With Vasomotor Symptoms
Condition: Vasomotor Symptoms
Interventions: Drug: desvenlafaxine succinate sustained release;   Drug: Placebo
4 Completed Establish The Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets (ACTFAST)
Conditions: Coronary Arteriosclerosis;   Diabetes Mellitus, Type 2;   Cerebrovascular Accident;   Dyslipidemia;   Peripheral Vascular Disease
Intervention: Drug: Atorvastatin (Lipitor)
5 Recruiting Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
Condition: Colorectal Cancer
Interventions: Drug: celecoxib;   Drug: fluorouracil;   Drug: leucovorin calcium;   Drug: oxaliplatin;   Other: placebo
6 Active, not recruiting Letrozole in Treating Women With Primary Breast Cancer Who Have Received 5 Years of Aromatase Inhibitor Therapy
Condition: Breast Cancer
Interventions: Drug: letrozole;   Other: placebo
7 Active, not recruiting Study of Denosumab as Adjuvant Treatment for Women With High Risk Early Breast Cancer Receiving Neoadjuvant or Adjuvant Therapy (D-CARE)
Condition: Breast Cancer
Interventions: Drug: Placebo;   Drug: Denosumab
8 Recruiting VERIFY:A Study to Compare Combination Regimen With Vildagliptin & Metformin Versus Metformin in Treatment-naïve Patients With Type 2 Diabetes Mellitus
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Placebo to vildagliptin;   Drug: vildagliptin;   Drug: Metformin
9 Recruiting A Study of the Effects of Canagliflozin (JNJ-28431754) on Renal Endpoints in Adult Participants With Type 2 Diabetes Mellitus
Conditions: Diabetes Mellitus, Type 2;   Albuminuria
Interventions: Drug: Placebo;   Drug: Canagliflozin, 100 mg;   Drug: Canagliflozin, 300 mg
10 Completed
Has Results
The SOX Trial: Compression Stockings to Prevent the Post-Thrombotic Syndrome
Condition: Deep Venous Thrombosis
Interventions: Device: Knee-length, graduated elastic compression stocking;   Device: Knee-length, placebo stocking
11 Completed Sargramostim in Decreasing Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer
Conditions: Head and Neck Cancer;   Oral Complications;   Radiation Toxicity
Interventions: Biological: sargramostim;   Procedure: quality-of-life assessment;   Radiation: radiation therapy
12 Terminated BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab
Condition: Breast Cancer
Interventions: Drug: Docetaxel;   Drug: Trastuzumab;   Drug: Carboplatin;   Drug: Bevacizumab;   Drug: 5-Fluorouracil;   Drug: Epirubicin;   Drug: Cyclophosphamide
13 Active, not recruiting A Study of Evacetrapib in High-Risk Vascular Disease
Condition: Cardiovascular Diseases
Interventions: Drug: Evacetrapib;   Drug: Placebo
14 Active, not recruiting Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
Conditions: Clear Cell Renal Cell Carcinoma;   Stage I Renal Cell Cancer;   Stage II Renal Cell Cancer;   Stage III Renal Cell Cancer
Interventions: Drug: sorafenib tosylate;   Drug: sunitinib malate;   Other: placebo;   Other: quality-of-life assessment;   Other: laboratory biomarker analysis
15 Unknown  ARISE – Aggressive Reduction of Inflammation Stops Events
Conditions: Atherosclerosis;   Coronary Artery Disease;   Myocardial Infarction;   Unstable Angina
Intervention: Drug: AGI-1067
16 Completed A Study of Capecitabine (Xeloda) as a First-line Therapy in Patients With Metastatic Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Drug: Oxaliplatin 130 mg/m^2;   Drug: Capecitabine 1000 mg/m^2;   Drug: Bevacizumab 7.5 mg/kg;   Drug: Placebo for bevacizumab 7.5 mg/kg;   Drug: Oxaliplatin 85 mg/m^2;   Drug: Leucovorin 200 mg/m^2;   Drug: Fluorouracil 400 mg/m^2;   Drug: Bevacizumab 5 mg/kg;   Drug: Placebo for bevacizumab 5 mg/kg
17 Active, not recruiting Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Biological: bleomycin sulfate;   Biological: filgrastim;   Biological: pegfilgrastim;   Drug: ABVD regimen;   Drug: BEACOPP regimen;   Drug: cyclophosphamide;   Drug: dacarbazine;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: prednisone;   Drug: procarbazine hydrochloride;   Drug: vinblastine sulfate;   Drug: vincristine sulfate
18 Recruiting A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Ticagrelor 90 mg;   Drug: Ticagrelor placebo
19 Completed A Trial to Study of the Effects of Eletriptan 40mg on Mild vs Moderate to Severe Pain Intensity of Migraine
Condition: Migraine
Intervention: Drug: eletriptan
20 Completed
Has Results
Exemestane or Anastrozole in Treating Postmenopausal Women Who Have Undergone Surgery for Primary Breast Cancer
Condition: Breast Cancer
Interventions: Drug: anastrozole;   Drug: exemestane

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years